[HTML][HTML] Examining the role of the noradrenergic locus coeruleus for predicting attention and brain maintenance in healthy old age and disease: an MRI structural …

ERG Plini, E O'Hanlon, R Boyle, F Sibilia, G Rikhye… - Cells, 2021 - mdpi.com
The noradrenergic theory of Cognitive Reserve (Robertson, 2013–2014) postulates that the
upregulation of the locus coeruleus—noradrenergic system (LC–NA) originating in the …

Neuropsychology and the dementia spectrum: Differential diagnosis, clinical management, and forensic utility

VL Begali - NeuroRehabilitation, 2020 - content.iospress.com
BACKGROUND: The utility of neuropsychology in the treatment and evaluation of
neuropsychological disorders and neurodegenerative diseases is supported by scientific …

[PDF][PDF] Kognitiivisten toimintojen muutokset-mikä on ikääntymistä, mikä sairautta?

E Vuoksimaa - Duodecim, 2019 - researchportal.helsinki.fi
Kognitiivinen ikääntyminen kuuluu läpi elämän tapahtuviin muutoksiin muistissa ja muissa
tiedon käsittelyyn liittyvissä toiminnoissa. Monet kognition osaalueet alkavat heiketä jo …

Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials

M Sanderson‐Cimino, JA Elman, XM Tu… - … Research & Clinical …, 2022 - Wiley Online Library
Abstract Introduction Practice effects (PEs) on cognitive tests obscure decline, thereby
delaying detection of mild cognitive impairment (MCI). Importantly, PEs may be present even …

[HTML][HTML] A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and …

GW Kim, BC Kim, KS Park, GW Jeong - Scientific reports, 2020 - nature.com
The efficacy of donepezil is well known for improving the cognitive performance in patients
with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Most of the recent …

[HTML][HTML] The use of episodic memory tests for screening in clinical trials for early Alzheimer's Disease: a comparison of the free and cued selective reminding test …

E Teng, PT Manser, M Shah, K Pickthorn, N Hu… - The Journal of …, 2023 - Springer
Background Screening procedures for early Alzheimer's disease (AD) trials seek to
efficiently identify participants who fulfill clinical and biomarker criteria for AD and enrich for …

Novel characterization of the relationship between verbal list‐learning outcomes and hippocampal subfields in healthy adults

S Cremona, L Zago, E Mellet, L Petit… - Human Brain …, 2021 - Wiley Online Library
The relationship between hippocampal subfield volumetry and verbal list‐learning test
outcomes have mostly been studied in clinical and elderly populations, and remain …

[HTML][HTML] Neuroimage biomarker identification of the conversion of mild cognitive impairment to Alzheimer's Disease

TH Kung, TC Chao, YR Xie, MC Pai, YM Kuo… - Frontiers in …, 2021 - frontiersin.org
An efficient method to identify whether mild cognitive impairment (MCI) has progressed to
Alzheimer's disease (AD) will be beneficial to patient care. Previous studies have shown that …

Tsallis-entropy segmentation through MRF and Alzheimer anatomic reference for brain magnetic resonance parcellation

M Azimbagirad, FH Simozo, ACS Senra Filho… - Magnetic Resonance …, 2020 - Elsevier
Quantifying the intracranial tissue volume changes in magnetic resonance imaging (MRI)
assists specialists to analyze the effects of natural or pathological changes. Since these …

[HTML][HTML] Effects of APOE ε2 on the fractional amplitude of low-frequency fluctuation in mild cognitive impairment: a study based on the resting-state functional MRI

X Liu, Q Zeng, X Luo, K Li, H Hong, S Wang… - Frontiers in Aging …, 2021 - frontiersin.org
Background Apolipoprotein E (APOE) ε2 is a protective genetic factor for Alzheimer's
disease (AD). However, the potential interaction effects between the APOE ε2 allele and …